Loading the player...
RESPITE: Evidence to Support a Switch Approach?
Share URL
Embed Code
Share by Email
Send to social websites
Report this video as inappropriate You can report this video if you think it to be inappropriate, we will review your submission soon. If your reason is not listed here, like copyright infringements, please contact us directly by email. Select your reason
Sexual Content Violent or Repulsive Content
Hateful or Abusive Content Harmful Dangerous Acts
Child Abuse Spam
Dr. Jim White discusses data from RESPITE, a novel prospective open-label study that evaluated sildenafil and tadalafil treated patients who switched therapy to riociguat. To earn up to 1.25 FREE credit hours for viewing this and other programs in this series, click the link below.